Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

TAPUR: Tester bruken av Food and Drug Administration (FDA)-godkjente legemidler som retter seg mot en spesifikk abnormitet i et svulstgen hos personer med kreft i avansert stadium (TAPUR)

18. september 2026 oppdatert av: American Society of Clinical Oncology

Studie for målrettet agent og profileringsbruksregister (TAPUR).

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.

NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers).

********************************************************************

Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress.

********************************************************************

Studieoversikt

Detaljert beskrivelse

The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial that aims to describe the safety and efficacy of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer that has a potentially actionable genomic variant. TAPUR will study Food and Drug Administration (FDA)-approved targeted therapies that are contributed by collaborating pharmaceutical companies, catalogue the choice of molecular profiling test by clinical oncologists and develop hypotheses for additional clinical trials.

Studietype

Intervensjonell

Registrering (Antatt)

4200

Fase

  • Fase 2

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Laurie Smith, MA
  • Telefonnummer: www.tapur.org
  • E-post: tapur@asco.org

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35294
        • Rekruttering
        • University of Alabama at Birmingham Comprehensive Cancer Center
        • Hovedetterforsker:
          • Mehmet Akce, MD
        • Ta kontakt med:
    • Arizona
      • Phoenix, Arizona, Forente stater, 85338
        • Rekruttering
        • Cancer Treatment Centers of America-Phoenix
        • Hovedetterforsker:
          • Sagun Shrestha, MD
        • Ta kontakt med:
    • California
      • Auburn, California, Forente stater, 95602
        • Rekruttering
        • Sutter Auburn
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
      • Berkeley, California, Forente stater, 94705
        • Rekruttering
        • Sutter Alta Bates
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
      • Los Angeles, California, Forente stater, 90025
        • Rekruttering
        • The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
        • Ta kontakt med:
        • Hovedetterforsker:
          • Omid Hamid, MD
      • Oakland, California, Forente stater, 94611
        • Rekruttering
        • Kaiser Permanente - Oakland Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • Palo Alto, California, Forente stater, 94301
      • Roseville, California, Forente stater, 95661
        • Rekruttering
        • Kaiser Permanente - Roseville Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • Roseville, California, Forente stater, 95661
        • Rekruttering
        • Sutter Roseville
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
      • Sacramento, California, Forente stater, 95814
        • Rekruttering
        • Kaiser Permanente - Sacramento Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • Sacramento, California, Forente stater, 95816
        • Rekruttering
        • Sutter Sacramento
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
      • San Francisco, California, Forente stater, 94115
        • Rekruttering
        • California Pacific Medical Center Research Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
      • San Francisco, California, Forente stater, 94080
        • Rekruttering
        • Kaiser Permanente - South San Francisco Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • San Francisco, California, Forente stater, 94115
        • Rekruttering
        • Kaiser Permanente - San Francisco Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • San Francisco, California, Forente stater, 94115
        • Rekruttering
        • Sutter Cancer Research Consortium
        • Ta kontakt med:
        • Hovedetterforsker:
          • Stacy D'Andre, MD
      • San Jose, California, Forente stater, 95119
        • Rekruttering
        • Kaiser Permanente - San Jose Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • San Leandro, California, Forente stater, 94577
        • Rekruttering
        • Kaiser Permanente - San Leandro Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • Santa Barbara, California, Forente stater, 93105
        • Rekruttering
        • Sutter Sansum Clinic
        • Hovedetterforsker:
          • Nitin Rohatgi, MD
        • Ta kontakt med:
      • Santa Clara, California, Forente stater, 95051
        • Rekruttering
        • Kaiser Permanente - Santa Clara Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
      • Santa Cruz, California, Forente stater, 95065
      • Santa Cruz, California, Forente stater, 994538
      • Sunnyvale, California, Forente stater, 94086
      • Vallejo, California, Forente stater, 94589
        • Rekruttering
        • Kaiser Permanente - Vallejo Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M. Suga, MD
      • Walnut Creek, California, Forente stater, 94596
        • Rekruttering
        • Kaiser Permanente - Walnut Creek Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M Suga, MD
    • Connecticut
      • Bridgeport, Connecticut, Forente stater, 06606
        • Rekruttering
        • Saint Vincent's Medical Center (SVMC)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wylie Hosmer, MD
      • Hartford, Connecticut, Forente stater, 06102
      • Meriden, Connecticut, Forente stater, 06451
      • New Britain, Connecticut, Forente stater, 06053
        • Rekruttering
        • The Hospital of Central Connecticut (HOCC) Cancer Center
        • Hovedetterforsker:
          • Wylie Hosmer, MD
        • Ta kontakt med:
      • Norwich, Connecticut, Forente stater, 06360
      • Torrington, Connecticut, Forente stater, 06790
      • Willimantic, Connecticut, Forente stater, 06226
    • Florida
      • Altamonte Springs, Florida, Forente stater, 32701
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Aventura, Florida, Forente stater, 33180
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Aventura
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Bonita Springs, Florida, Forente stater, 34135
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Bradenton, Florida, Forente stater, 34211
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Brandon, Florida, Forente stater, 33511
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Cape Coral, Florida, Forente stater, 33909
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Clearwater, Florida, Forente stater, 33761
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Coral Gables, Florida, Forente stater, 33146
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Lennar
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Deerfield Beach, Florida, Forente stater, 33442
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Deerfield Beach
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Fort Lauderdale, Florida, Forente stater, 33308
      • Fort Myers, Florida, Forente stater, 33901
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Fort Myers, Florida, Forente stater, 33905
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Fort Myers, Florida, Forente stater, 33908
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Gainesville, Florida, Forente stater, 32610
        • Rekruttering
        • University of Florida Health
        • Hovedetterforsker:
          • Thomas George, MD
        • Ta kontakt med:
      • Gainesville, Florida, Forente stater, 32605
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Largo, Florida, Forente stater, 33770
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Lecanto, Florida, Forente stater, 34461
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami Sylvester Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Alex's Place
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Griffin Cancer Research Building
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Miami, Florida, Forente stater, 33176
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Kendall
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Miami, Florida, Forente stater, 33181
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Sole Mia
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Naples, Florida, Forente stater, 34102
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Ocala, Florida, Forente stater, 34474
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Orange City, Florida, Forente stater, 32763
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Orlando, Florida, Forente stater, 32806
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Plantation, Florida, Forente stater, 33324
        • Rekruttering
        • University of Miami/Sylvester Cancer Institute - Plantation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carmen Calfa, MD
      • Port Charlotte, Florida, Forente stater, 33980
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Sarasota, Florida, Forente stater, 34236
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Sarasota, Florida, Forente stater, 34239
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • St. Petersburg, Florida, Forente stater, 33701
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Tampa, Florida, Forente stater, 33607
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Tavares, Florida, Forente stater, 32778
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • The Villages, Florida, Forente stater, 32159
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Trinity, Florida, Forente stater, 34655
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
      • Venice, Florida, Forente stater, 34285
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Venice, Florida, Forente stater, 34292
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists South / Sarah Cannon Research Institute
      • Winter Park, Florida, Forente stater, 32789
        • Aktiv, ikke rekrutterende
        • Florida Cancer Specialists North / Sarah Cannon Research Institute
    • Georgia
      • Atlanta, Georgia, Forente stater, 30322
        • Rekruttering
        • Emory University Winship Cancer Institute
        • Hovedetterforsker:
          • Olatunji Alese, MD
        • Ta kontakt med:
      • Atlanta, Georgia, Forente stater, 30265
        • Rekruttering
        • Cancer Treatment Centers of America - Atlanta
        • Hovedetterforsker:
          • Bamidele Adesunloye, MD
        • Ta kontakt med:
          • Elizabeth McKoy, RN, BSN
          • Telefonnummer: 770-400-7177
          • E-post: emckoy@coh.org
      • Savannah, Georgia, Forente stater, 31405
        • Rekruttering
        • Summit Cancer Care
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Savannah, Georgia, Forente stater, 31405
        • Rekruttering
        • Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Savannah, Georgia, Forente stater, 31405
        • Rekruttering
        • Lewis Cancer & Research Pavilion at the Melanoma, Skin Cancer & Sarcoma Institute
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Savannah, Georgia, Forente stater, 31405
        • Rekruttering
        • Lewis Cancer & Research Pavilion
        • Ta kontakt med:
          • Stephanie Smith, RN, MSN, OCN
          • Telefonnummer: 912-819-5723
          • E-post: smiths1@sjchs.org
        • Hovedetterforsker:
          • Mark Taylor, MD
    • Hawaii
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • The Queen's Medical Center - POB I
        • Hovedetterforsker:
          • Jared Acoba, MD
        • Ta kontakt med:
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • The Queen's Medical Center - Punchbowl
        • Hovedetterforsker:
          • Jared Acoba, MD
        • Ta kontakt med:
      • Honolulu, Hawaii, Forente stater, 96817
        • Rekruttering
        • The Queen's Medical Center - Kuakini
        • Hovedetterforsker:
          • Jared Acoba, MD
        • Ta kontakt med:
      • ‘Ewa Beach, Hawaii, Forente stater, 96706
        • Rekruttering
        • The Queen's Medical Center - West Oahu
        • Hovedetterforsker:
          • Jared Acoba, MD
        • Ta kontakt med:
    • Illinois
      • Chicago, Illinois, Forente stater, 60099
        • Rekruttering
        • Cancer Treatment Centers of America-Chicago
        • Hovedetterforsker:
          • Evan Pisick, MD
        • Ta kontakt med:
    • Indiana
      • Indianapolis, Indiana, Forente stater, 46250
        • Rekruttering
        • Community Health Network (The University of Texas MD Anderson Cancer Center)
        • Hovedetterforsker:
          • Funda Meric-Bernstam, MD
        • Ta kontakt med:
    • Maine
      • Augusta, Maine, Forente stater, 04330
        • Rekruttering
        • Harold Alfond Center for Cancer Care
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lindsay Hathaway, MD
      • Augusta, Maine, Forente stater, 04330
        • Rekruttering
        • Jackson Laboratory - Maine Cancer Genomics Initiative
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jens Rueter, MD
      • Belfast, Maine, Forente stater, 04915
        • Rekruttering
        • Waldo County General Hospital
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Biddeford, Maine, Forente stater, 04005
        • Rekruttering
        • SMHC Cancer Care and Blood Disorders -Biddeford
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
      • Brewer, Maine, Forente stater, 04412
        • Rekruttering
        • Northern Light Cancer Care
        • Hovedetterforsker:
          • Sarah Sinclair, MD
        • Ta kontakt med:
      • Brewer, Maine, Forente stater, 04412
        • Rekruttering
        • Raish Peavey Haskell Children's Cancer and Treatment Center
        • Hovedetterforsker:
          • Sarah Sinclair, MD
        • Ta kontakt med:
      • Brunswick, Maine, Forente stater, 04011
        • Rekruttering
        • MaineHealth Cancer Care -Brunswick
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Kennebunk, Maine, Forente stater, 04043
        • Rekruttering
        • New England Cancer Specialist
        • Hovedetterforsker:
          • Christian Thomas, MD
        • Ta kontakt med:
      • Kittery, Maine, Forente stater, 03904
        • Rekruttering
        • York Hopsital Oncology & Infusion Care in Kittery
        • Hovedetterforsker:
          • Marilyn McLaughlin, MD
        • Ta kontakt med:
      • Norway, Maine, Forente stater, 04268
        • Rekruttering
        • Stephens Memorial Hospital
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Rockport, Maine, Forente stater, 04856
        • Rekruttering
        • Penobscot Bay Medical Center
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Sanford, Maine, Forente stater, 04073
        • Rekruttering
        • SMHC Cancer Care and Blood Disorders -Sandford
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Scarborough, Maine, Forente stater, 04074
        • Rekruttering
        • Maine Children's Cancer Program
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Scarborough, Maine, Forente stater, 04074
        • Rekruttering
        • Maine Medical Partner's Women's Health
        • Hovedetterforsker:
          • Roger Inhorn, MD
        • Ta kontakt med:
          • Jen - Dalton, MHA, BSN, RN
          • Telefonnummer: 2072948291
          • E-post: JDalton@mmc.org
      • Scarborough, Maine, Forente stater, 04074
        • Rekruttering
        • New England Cancer Specialist
        • Hovedetterforsker:
          • Christian Thomas, MD
        • Ta kontakt med:
      • South Portland, Maine, Forente stater, 04106
        • Rekruttering
        • MaineHealth Cancer Care -South Portland
        • Ta kontakt med:
          • Jen Dalton, MHA, BSN, RN
          • Telefonnummer: 207-294-8291
          • E-post: JDalton@mmc.org
        • Hovedetterforsker:
          • Roger Inhorn, MD
      • Topsham, Maine, Forente stater, 04086
        • Rekruttering
        • New England Cancer Specialist
        • Hovedetterforsker:
          • Christian Thomas, MD
        • Ta kontakt med:
      • Wells, Maine, Forente stater, 04090
        • Rekruttering
        • York Hospital Oncology & Infusion Care in Wells
        • Hovedetterforsker:
          • Marilyn McLaughlin, MD
        • Ta kontakt med:
      • York Village, Maine, Forente stater, 03909
        • Rekruttering
        • York Hospital Oncology & Infusion Care in York
        • Hovedetterforsker:
          • Marilyn McLaughlin, MD
        • Ta kontakt med:
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • Aktiv, ikke rekrutterende
        • University of Michigan
      • Ann Arbor, Michigan, Forente stater, 48106
      • Detroit, Michigan, Forente stater, 48236
      • Flint, Michigan, Forente stater, 48503
      • Grand Rapids, Michigan, Forente stater, 49503
        • Rekruttering
        • Cancer Research Consortium of West Michigan
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen J. Yost, MD
      • Lansing, Michigan, Forente stater, 48912
      • Livonia, Michigan, Forente stater, 48154
      • Pontiac, Michigan, Forente stater, 48341
      • Saginaw, Michigan, Forente stater, 48601
      • Traverse City, Michigan, Forente stater, 48341
        • Rekruttering
        • Michigan Cancer Research Consortium
        • Hovedetterforsker:
          • Philip Stella, MD
        • Ta kontakt med:
        • Ta kontakt med:
          • Telefonnummer: 877-590-5995
      • Warren, Michigan, Forente stater, 48093
    • Nebraska
      • Omaha, Nebraska, Forente stater, 68198
        • Rekruttering
        • University of Nebraska Medical Center
        • Hovedetterforsker:
          • Alissa Marr, MD
        • Ta kontakt med:
    • New Hampshire
      • Concord, New Hampshire, Forente stater, 03103
        • Rekruttering
        • NH Oncology - Hematology, PA
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael Buff, MD
      • Manchester, New Hampshire, Forente stater, 03103
        • Rekruttering
        • Solinsky Center for Cancer Care
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael Buff, MD
      • Portsmouth, New Hampshire, Forente stater, 03801
        • Rekruttering
        • New England Cancer Specialist
        • Hovedetterforsker:
          • Christian Thomas, MD
        • Ta kontakt med:
    • New Mexico
      • Albuquerque, New Mexico, Forente stater, 87110
        • Rekruttering
        • Presbyterian Kaseman Hospital
        • Hovedetterforsker:
          • Bernard Tawfik, MD
        • Ta kontakt med:
      • Albuquerque, New Mexico, Forente stater, 87102
        • Rekruttering
        • Lovelace Medical Center - Saint Joseph Square
        • Hovedetterforsker:
          • Bernard Tawfik, MD
        • Ta kontakt med:
      • Albuquerque, New Mexico, Forente stater, 87131
        • Rekruttering
        • The University of New Mexico Comprehensive Cancer Center
        • Hovedetterforsker:
          • Bernard Tawfik, MD
        • Ta kontakt med:
      • Las Cruces, New Mexico, Forente stater, 88011
        • Rekruttering
        • Memorial Medical Center
        • Hovedetterforsker:
          • Bernard Tawfik, MD
        • Ta kontakt med:
      • Rio Rancho, New Mexico, Forente stater, 87124
        • Rekruttering
        • Presbyterian Rust Medical Center
        • Hovedetterforsker:
          • Bernard Tawfik, MD
        • Ta kontakt med:
    • New York
      • Lake Success, New York, Forente stater, 11042
        • Rekruttering
        • Northwell Health Monter Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marina Frimer, MD
      • Mount Kisco, New York, Forente stater, 10549
        • Rekruttering
        • Northern Westchester Hospital
        • Hovedetterforsker:
          • Marina Frimer, MD
        • Ta kontakt med:
      • New Hyde Park, New York, Forente stater, 11040
        • Rekruttering
        • Cohen Children's Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marina Frimer, MD
      • New York, New York, Forente stater, 10065
        • Rekruttering
        • Manhattan Eye, Ear, and Throat Hospital
        • Hovedetterforsker:
          • Marina Frimer, MD
        • Ta kontakt med:
      • New York, New York, Forente stater, 10305
        • Rekruttering
        • Staten Island University Hospital
        • Hovedetterforsker:
          • Marina Frimer, MD
        • Ta kontakt med:
        • Ta kontakt med:
      • Rego Park, New York, Forente stater, 11374
        • Rekruttering
        • Queens Cancer Center
        • Hovedetterforsker:
          • Marina Frimer, MD
        • Ta kontakt med:
      • Sleepy Hollow, New York, Forente stater, 10591
        • Rekruttering
        • Phelps Hospital
        • Hovedetterforsker:
          • Marina Frimer, MD
        • Ta kontakt med:
        • Ta kontakt med:
    • North Carolina
      • Chapel Hill, North Carolina, Forente stater, 27599
        • Rekruttering
        • Lineberger Comprehensive Cancer Center
        • Hovedetterforsker:
          • Shetal Patel, MD
        • Ta kontakt med:
      • Charlotte, North Carolina, Forente stater, 28277
        • Rekruttering
        • Atrium Health's Levine Cancer Institute
        • Hovedetterforsker:
          • Kathryn F. Mileham, MD, FACP
        • Ta kontakt med:
    • North Dakota
      • Bismarck, North Dakota, Forente stater, 58501
        • Rekruttering
        • Sanford Health- Bismarck
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Kurniali, MD
      • Fargo, North Dakota, Forente stater, 58122
        • Rekruttering
        • Sanford Health- Fargo
        • Ta kontakt med:
        • Hovedetterforsker:
          • Anu Gaba, MD
    • Ohio
      • Cincinnati, Ohio, Forente stater, 45219
        • Rekruttering
        • University of Cincinnati Medical Center
        • Hovedetterforsker:
          • Davendra Sohal, MD
        • Ta kontakt med:
      • Kettering, Ohio, Forente stater, 45429
        • Rekruttering
        • Kettering Health
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lex Leonhardt, DO
      • West Chester, Ohio, Forente stater, 45069
        • Rekruttering
        • West Chester Hospital
        • Hovedetterforsker:
          • Trisha Wise-Draper, MD
        • Ta kontakt med:
    • Oregon
      • Portland, Oregon, Forente stater, 97213
        • Rekruttering
        • Providence Health & Services
        • Hovedetterforsker:
          • Evthokia Hobbs, MD
        • Ta kontakt med:
    • Pennsylvania
      • Allentown, Pennsylvania, Forente stater, 18103
      • Bethlehem, Pennsylvania, Forente stater, 18017
      • East Stroudsburg, Pennsylvania, Forente stater, 18301
      • Hazleton, Pennsylvania, Forente stater, 18201
      • Philadelphia, Pennsylvania, Forente stater, 19111
        • Rekruttering
        • Fox Chase Cancer Center
        • Hovedetterforsker:
          • Margaret von Mehren, MD
        • Ta kontakt med:
    • South Carolina
      • Bluffton, South Carolina, Forente stater, 29910
        • Rekruttering
        • SC Cancer Specialists at St. Joseph's/Candler Bluffton
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Bluffton, South Carolina, Forente stater, 29910
        • Rekruttering
        • St. Joseph's/Candler Smith
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Bluffton, South Carolina, Forente stater, 29910
        • Rekruttering
        • Summit Cancer Care at St. Josph's/Candler Bluffton
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
      • Hilton Head Island, South Carolina, Forente stater, 29926
        • Rekruttering
        • South Carolina Cancer Specialists
        • Hovedetterforsker:
          • Mark Taylor, MD
        • Ta kontakt med:
    • South Dakota
      • Sioux Falls, South Dakota, Forente stater, 57104
        • Rekruttering
        • Sanford Cancer Center Oncology Clinic and Pharmacy
        • Hovedetterforsker:
          • Steven Powell, MD
        • Ta kontakt med:
    • Tennessee
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Tennessee Oncology - Nashville / Sarah Cannon Research Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Meredith McKean, MD, MPH
    • Texas
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • The University of Texas MD Anderson Cancer Center
        • Hovedetterforsker:
          • Funda Meric-Bernstam, MD
        • Ta kontakt med:
    • Utah
      • Cedar City, Utah, Forente stater, 84720
        • Rekruttering
        • Cedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer Center
        • Hovedetterforsker:
          • Ramya Thota, MD
        • Ta kontakt med:
        • Hovedetterforsker:
          • Derrick Haslem, MD
      • Salt Lake City, Utah, Forente stater, 84107
        • Rekruttering
        • Intermountain Healthcare
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ramya Thota, M.D.
        • Hovedetterforsker:
          • Derrick Haslem, M.D.
      • St. George, Utah, Forente stater, 84770
        • Rekruttering
        • Dixie Regional Medical Center-River Road Campus
        • Hovedetterforsker:
          • Ramya Thota, MD
        • Ta kontakt med:
        • Hovedetterforsker:
          • Derrick Haslem, MD
    • Virginia
      • Fairfax, Virginia, Forente stater, 22042
        • Rekruttering
        • Inova Schar Cancer Institute
        • Hovedetterforsker:
          • Timothy Cannon, MD
        • Ta kontakt med:
    • Washington
      • Bonney Lake, Washington, Forente stater, 98391
        • Rekruttering
        • Northwest Medical Specialties
        • Ta kontakt med:
        • Hovedetterforsker:
          • Frank Senecal, MD
      • Federal Way, Washington, Forente stater, 98003
        • Rekruttering
        • Northwest Medical Specialties
        • Ta kontakt med:
        • Hovedetterforsker:
          • Frank Senecal, MD
      • Gig Harbor, Washington, Forente stater, 98332
        • Rekruttering
        • Northwest Medical Specialties
        • Ta kontakt med:
        • Hovedetterforsker:
          • Frank Senecal, MD
      • Olympia, Washington, Forente stater, 98502
        • Rekruttering
        • Northwest Medical Specialties
        • Ta kontakt med:
        • Hovedetterforsker:
          • Frank Senecal, MD
      • Puyallup, Washington, Forente stater, 98373
        • Rekruttering
        • Northwest Medical Specialties
        • Hovedetterforsker:
          • Frank Senecal, MD
        • Ta kontakt med:
      • Seattle, Washington, Forente stater, 98104
        • Rekruttering
        • Swedish Cancer Institute
        • Hovedetterforsker:
          • Philip Gold, MD
        • Ta kontakt med:
      • Tacoma, Washington, Forente stater, 98405
        • Rekruttering
        • Northwest Medical Specialties
        • Hovedetterforsker:
          • Frank Senecal, MD
        • Ta kontakt med:
    • Wisconsin
      • Burlington, Wisconsin, Forente stater, 53105
        • Rekruttering
        • Aurora Cancer Care - Burlington
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Germantown, Wisconsin, Forente stater, 53022
        • Rekruttering
        • Aurora Health Care - Germantown Health Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Grafton, Wisconsin, Forente stater, 53024
        • Rekruttering
        • Aurora Cancer Care - Grafton
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Green Bay, Wisconsin, Forente stater, 54311
        • Rekruttering
        • Aurora BayCare Medical Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Kenosha, Wisconsin, Forente stater, 53142
        • Rekruttering
        • Aurora Cancer Care - Kenosha South
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Marinette, Wisconsin, Forente stater, 54143
        • Rekruttering
        • Aurora Bay Area Medical Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Milwaukee, Wisconsin, Forente stater, 53215
        • Rekruttering
        • Aurora St. Luke's Medical Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Milwaukee, Wisconsin, Forente stater, 53209
        • Rekruttering
        • Aurora Cancer Care Milwaukee
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Milwaukee, Wisconsin, Forente stater, 53223
        • Rekruttering
        • Aurora Sinai Medical Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Milwaukee, Wisconsin, Forente stater, 53227
        • Rekruttering
        • Aurora West Allis Medical Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Oshkosh, Wisconsin, Forente stater, 54904
        • Rekruttering
        • Vince Lombardi Cancer Clinic - Oshkosh
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Racine, Wisconsin, Forente stater, 53406
        • Rekruttering
        • Aurora Cancer Care - Racine
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Vince Lombardi Cancer Center
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Summit, Wisconsin, Forente stater, 53066
        • Rekruttering
        • Aurora Medical Center in Summit
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Two Rivers, Wisconsin, Forente stater, 54241
        • Rekruttering
        • Vince Lombardi Cancer Clinic - Two Rivers
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
      • Wauwatosa, Wisconsin, Forente stater, 53226
        • Rekruttering
        • Aurora Cancer Care - Milwaukee West
        • Hovedetterforsker:
          • Antony Ruggeri, MD
        • Ta kontakt med:
    • Puerto Rico
      • Cayey, Puerto Rico, Puerto Rico, 00737
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD
      • Dorado, Puerto Rico, Puerto Rico, 00646
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD
      • Manati, Puerto Rico, Puerto Rico, 00674
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Crus Correa, MD
      • Mayagüez, Puerto Rico, Puerto Rico, 00680
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD
      • Ponce, Puerto Rico, Puerto Rico, 00730
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD
      • San Juan, Puerto Rico, Puerto Rico, 00909
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD
      • San Juan, Puerto Rico, Puerto Rico, 00935
        • Rekruttering
        • PanOncology Trials
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Cruz Correa, MD

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

12 år og eldre (Barn, Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • 12 years of age or older (*Restrictions apply. Not all therapies are available for patients <18)

  • Histologically-proven locally advanced or metastatic solid tumor, multiple myeloma or B cell non-Hodgkin lymphoma who is no longer benefiting from standard anti-cancer treatment or for whom, in the opinion of the treating physician, no such treatment is available or indicated (except under the circumstance in which the TAPUR arm is designed to provide additional evidence to support an existing FDA indication).

  • Performance status 0-2 (Per Eastern Cooperative Oncology Group (ECOG) criteria)

  • Patients must have acceptable organ function as defined below. However, as noted above, drug-specific inclusion/exclusion criteria specified in the protocol appendix for each agent will take precedence for this and all inclusion criteria:

    1. Absolute neutrophil count ≥ 1500 µl
    2. Hemoglobin ≥ 9.0 g/dl
    3. Platelets ≥ 75,000/µl
    4. Total bilirubin < 2.0 mg/ dl, except in patients with Gilbert's Syndrome
    5. Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT) and alanine aminotransferase (ALT) serum glutamic-pyruvic transaminase (SGPT) < 2.5 x institutional upper limit of normal (ULN) (or < 5 x ULN in patients with known hepatic metastases)
    6. Serum creatinine ≤ 1.5 × ULN or calculated or measured creatinine clearance ≥ 50 mL/min/1.73 m2
  • Patients must have disease that can be objectively measured by physical, laboratory or radiographic exam (per RECIST v1.1 for solid tumor, Lugano criteria for non-Hodgkin lymphoma or International Myeloma Working Group criteria for multiple myeloma).

  • Results must be available from a genomic test or immunohistochemistry (IHC) test for protein expression performed in a Clinical Laboratory Improvement Amendments (CLIA)-certified and College of American Pathologists (CAP)-accredited or New York State accredited (for labs offering services to residents of NY) laboratory. Labs that have registered the test with the NIH Genetic Testing Registry or that provide a report that has been designated as optimized for TAPUR participation are preferred, but not required. The genomic or IHC test used to qualify a patient for participation in TAPUR may have been performed on any specimen of the patient's tumor obtained at any point during the patient's care at the discretion of the patient's treating physician. Genomic assays performed on cell-free DNA in plasma ("liquid biopsies") will also be acceptable if the genomic analysis is performed in a laboratory that meets the criteria described above.

  • Ability to understand and the willingness to sign a written informed consent/assent document.

  • Have a tumor genomic profile for which single agent treatment with one of the FDA approved targeted anti-cancer drugs included in this study has potential clinical benefit based on the criteria described in protocol.

  • For orally administered drugs, the patient must be able to swallow and tolerate oral medication and must have no known malabsorption syndrome.

  • Because of the risks of drug treatment to the developing fetus, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) for the duration of study participation, and for four months following completion of study therapy. Should a woman become pregnant or suspect she is pregnant while participating in this study or if she is the partner of a male participant in this study and becomes pregnant while he is participating in this study, she should inform her or her partner's treating physician immediately as well as her obstetrician. Female study patients who become pregnant must immediately discontinue treatment with any study therapy. Male patients should avoid impregnating a female partner. Male study patients, even if surgically sterilized, (i.e. post-vasectomy) must agree to one of the following: practice effective barrier contraception during the entire study treatment period and for a specified amount of time the last dose of study treatment, or completely abstain from sexual intercourse.

Note: TAPUR does not explicitly exclude any type of solid tumor, but the patient must have measurable and evaluable disease per RECIST v1.1.

Exclusion Criteria:

  • Patients whose disease is not measurable or cannot be assessed by radiographic imaging or physical examination (e.g., elevated serum tumor marker only) are not eligible
  • Patients with primary brain tumors or new, untreated or progressive leptomeningeal metastases are excluded
  • Patients with previously treated brain metastases or previously treated leptomeningeal disease are eligible, provided that the patient has not experienced a seizure or had a clinically significant change in neurological status within the 1 months prior to registration. All patients with previously treated brain metastases must be clinically stable for at least 1 month after completion of treatment and off steroid treatment for one month prior to study enrollment.
  • Patients with known progressive brain metastases are eligible but additional eligibility criteria apply.

Note: there are additional exclusion criteria that may apply

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Annen: Group 5 (CSF1R,PDGFR,VEGFR)

Participants receive sunitinib - dosage, frequency and duration per label; acceptable genomic matches include CSF1R, PDGFR, VEGFR1/2/3, KIT, FLT-3, RET, FGFR1/2/3, VHL amplifications or mutations

drug

Andre navn:
  • Sutent
Annen: Group 8 (ERBB2)

Participants receive trastuzumab and pertuzumab - dosage, frequency and duration per label; acceptable genomic matches include ERBB2 amplification or overexpression, and specific ERBB2 mutations

drug

Andre navn:
  • Herceptin og Perjeta
Annen: Group 9 (BRAF V600E/D/K/R)

Participants receive vemurafenib and cobimetinib - dosage, frequency and duration per label; acceptable genomic matches include BRAF V600E/D/K/R mutations

drug

Andre navn:
  • Zelboraf og Cotellic
Annen: Group 14 (BRCA1/2; ATM)

Participants receive olaparib - dosage, frequency and duration per label; acceptable genomic matches include germline or somatic BRCA1/2 inactivating mutations; ATM mutations or deletions

drug

Andre navn:
  • Lynparza
Annen: Group 16 (MSI-H, high mutational load and others)

Participants receive nivolumab and ipilimumab - dosage, frequency and duration per label; acceptable genomic matches include MSI high status, high tumor mutational burden, MLH1, MSH2/6, PMS2, EPCAM mutations, specific POLE or POLD1 mutations, BRCA1/2, ATM, MSH3, PMS1, MLH3, EXO1, RFC1/2/3/4/5, PCNA, RPA1/2/3/4, and SSBP1 loss of function mutations

drug

Andre navn:
  • Opdivo og Yervoy
Annen: Group 17 (CDKN2A, CDK4, CDK6)

Participants receive abemaciclib - dosage, frequency and duration per label; acceptable genomic matches include CDKN2A loss or mutation, CDK4, CDK6 amplifications, CDKN2B loss or mutation

drug

Andre navn:
  • Verzenio
Annen: Group 19 (BRCA1/2, PALB2)

Participants receive talazoparib - dosage, frequency and duration per label; acceptable genomic matches include germline or somatic BRCA1/2 and PALB2 mutations

drug

Andre navn:
  • Talzenna
Annen: Group 21 (BRCA1/2, PALB2, ATM, and others)

Participants receive atezolizumab plus talazoparib - dosage, frequency and duration per label; acceptable genomic matches include germline or somatic mutations in BRCA1/2, PALB2, ATM, ATR, CHEK2, FANCA, RAD51C, NBN, MLH1, MRE11A, CDK12; positive genomic instability score reported on the Myriad MyChoice CDx test; or Genomic Loss of Heterozygosity (LOH) Score above threshold as reported on a FoundationOne CDx test or another qualifying test for TAPUR with MTB approval

drug

Andre navn:
  • Tecentriq og Talzenna
Annen: Group 24 (ERBB2)

Participants receive tucatinib plus trastuzumab SC - dosage, frequency and duration per label; acceptable genomic matches include ERBB2 amplification or overexpression, and specific ERBB2 mutations

drug

Andre navn:
  • Tukysa og Herceptin Hylecta
Annen: Group 25

Participants receive futibatinib- dosage, frequency and duration per label; acceptable genomic matches include FGFR 1,2,3,4 fusion (or other rearrangement) or mutation

drug

Andre navn:
  • Lytgobi
Annen: Group 26 (BRAF V600 E mutation )

Participants receive Dabrafenib plus Trametinib - dosage, frequency and duration per label; acceptable genomic matches include BRAF V600 E mutation .

Drug

Andre navn:
  • Mekinist
  • tanfinlar
Annen: Group 27 (ERBB2 amplification, ERBB2 (HER2) IHC2+ or IHC3+ overexpression)

Participants receive Fam-trastuzumab deruxtecan-nxki (ENHERTU®) - dosage, frequency and duration per label; acceptable genomic matches include ERBB2 amplification, For NSCLC Only-ERBB2 (HER2) IHC2+ or IHC3+ overexpression without ERBB2 amplification)

Drug

Andre navn:
  • Enhertu

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Objective Response Rate defined as % of participants in a cohort with complete or partial response or with stable disease according to standard response criteria
Tidsramme: Assessed at 16 weeks of treatment

Each cohort includes participants with the same tumor type, genomic variant and study drug. For solid tumors, the Response Evaluation Criteria for Solid Tumors (RECIST) criteria will be used, for non-Hodgkin Lymphoma, the Lugano Criteria will be used, and for multiple myeloma, the International Uniform Response Criteria for Multiple Myeloma will be used.

Assessed at 16 weeks of treatment

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall survival (OS)
Tidsramme: Duration of survival from registration on study until death from any cause, assessed throughout end of study, up to 3 years

OS will be estimated using the Kaplan-Meier method

Duration of survival from registration on study until death from any cause, assessed throughout end of study, up to 3 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

14. mars 2016

Primær fullføring (Antatt)

31. desember 2027

Studiet fullført (Antatt)

31. desember 2028

Datoer for studieregistrering

Først innsendt

11. februar 2016

Først innsendt som oppfylte QC-kriteriene

23. februar 2016

Først lagt ut (Antatt)

26. februar 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere